Cibus, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Peter R. Beetham, with a market cap of $96.0M.
Common questions about Cibus, Inc.
Cibus, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $1.5M.
Cibus, Inc. has approximately 183 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.